SuperVision Entertainment Inc.: (PINKSHEETS: SVET)

Supervision is pleased to announce that it is introducing an exciting home business opportunity with potential staggering profits by marketing a newly FDA approved product to the overweight and diabetic communities.

Distributors are expected to enroll in this exciting program from around the world. Two patents and FDA approval cover the product. For those people on a diet, who are overweight or obese, or are diabetic, this product is a must.

Distributors can enroll into this exciting home business program for as little as $5,000 U.S. Dollars. This includes start up stock, and start up advice on how to initiate the business. Certain exclusive licenses for cities, states and countries can be negotiated on a first come first served basis.

Diabetes is now considered to be a chronic world wide epidemic. Over 400 million people are currently diagnosed as diabetics, and an estimated 800 million more have diabetes but have not yet been diagnosed. Approximately 1/6th of the world's population now has diabetes. 2,500,000 people die each year from diabetes related problems, and diabetes is often associated with overweight or obesity. The diet, overweight, obesity and diabetic market is huge and is growing rapidly. Now an incredible, original, FDA approved and patent protected product is available for the first time to this market.

Highly skilled and knowledgeable scientists with impeccable credentials developed this groundbreaking product. A state of the art production plant exists and is expected to double in size soon.

If you would be interested in this opportunity to work at home with the potential for unlimited earnings, please contact us immediately. Applications are on a first come first served basis only.

For further info contact: superv0007@hotmail.com

Safe Harbor Statement

All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the Company's future, revenues and earnings, and all other forward-looking statements (i.e. future operational results and sales) are subject to assumptions and beliefs based on current information known to the Company and are factors that are subject to uncertainties, risks and other influences which are outside the Company's control, and which may yield results differing materially and substantially from those anticipated. Any reference to a private placement is not an offering or a solicitation of any kind and is to be considered a notice only. All information is subject to change.

Add to Digg Bookmark with del.icio.us Add to Newsvine

For further info contact: SuperVision Entertainment Inc. Email Contact

BioNeutra (CE) (USOTC:BIMO)
Historical Stock Chart
From Feb 2025 to Mar 2025 Click Here for more BioNeutra (CE) Charts.
BioNeutra (CE) (USOTC:BIMO)
Historical Stock Chart
From Mar 2024 to Mar 2025 Click Here for more BioNeutra (CE) Charts.